The Europe molecular oncology diagnostics market, valued at $606M in 2024, is projected to grow at a 10.78% CAGR, reaching $1.52B by 2033...Despite logistical hurdles, Western Europe leads adoption due to supportive policies and research funding ... .
The Human Papillomavirus (HPV) Testing Market is projected to grow from USD 1.52 billion in 2024 to USD 3.62 billion by 2033, at a 10.11% CAGR from 2025 ... Notable market segments include consumables, immunodiagnostics, and PCR testing ... .